Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator

British Journal of Ophthalmology

Volumn 90, Issue 4, 2006, Pages 429-431

  Singh, R P ^a   Patel, C ^b   Sears, Jonathan ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; CILIARY DISK; CLINICAL ARTICLE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HEMORRHAGE; RETINA NEOVASCULARIZATION; SUPINE POSITION; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRALESIONAL; MACULAR DEGENERATION; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTURE; RETINAL HEMORRHAGE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 33645289964     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.085001     Document Type: Article

References (29)

1. Avery RL, Fekrat S, Hawkins BS, et al. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 1996;16:183-9.
2. Bennett SR, Folk JC, Blodi CF, et al. Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol 1990;109:33-7.
3. Berrocal MH, Lewis ML, Flynn HW Jr. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol 1996;122:486-93.
4. Scupola A, Coscas G, Soubrane G, et al. Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica 1999;213:97-102.
5. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 1982;94:762-73.
6. Toth CA, Morse LS, Hjelmeland LM, et al. Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol 1991;109:723-9.
7. Lewis H, Resnick SC, Flannery JG, et al. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Am J Ophthalmol 1991;111:197-204.
8. Tennant MT, Borrillo JL, Regillo CD. Management of submacular hemorrhage. Ophthalmol Clin North Am 2002;15:445-52, vi.
9. Scheider A, Gundisch O, Kampik A. Surgical extraction of subfoveal choroidal new vessels and submacular haemorrhage in age-related macular degeneration: results of a prospective study. Graefes Arch Clin Exp Ophthalmol 1999;237:10-15.
10. Vander JF, Federman JL, Greven C, et al. Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration. Ophthalmology 1991;98:23-7.
11. Wade EC, Flynn Jr HW, Olsen KR, et al. Subretinal hemorrhage management by pars plan vitrectomy and internal drainage. Arch Ophthalmol 1990;108:973-8.
12. de Juan E Jr, Machemer R. Viteous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol 1988;105:25-9.
13. Peyman GA, Nelson NC Jr, Alturki W, et al. Tissue plasminogen activating factor assisted removal of subretinal hemorrhage. Ophthalmic Surg 1991;22:575-82.
14. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 1994;118:559-68.
15. Lim JI, Drews-Botsh C, Sternberg P Jr, et al. Submacular hemorrhage removal. Ophthalmology 1995;102:1393-9.
16. Moriarty AP, McAllister IL, Constable IJ. Initial clinical experience with tissue plasminogen activator (tPA) assisted removal of submacular hemorrhage. Eye 1995;9:582-8.
17. Saika S, Yamanaka A, Minamide A, et al. Subretinal administration of tissue-type plasminogen activator to speed the drainage of subretinal hemorrhage. Graefes Arch Clin Exp Ophthalmol 1998;236:196-201.
18. Heriot WJ. Intravitreal gas and tPA: an outpatient procedure for submacular hemorrhage. Paper presented at the American Academy of Ophthalmology Annual Vitreoretinal Update; Chicago, IL, October, 1996.
19. Hesse L, Blodi B. Treating subretinal hemorrhage with tissue plasminogen activator [letter]. Arch Ophthalmol 2002;120:102-3.
20. Boone DE, Boldt HC, Ross RD, et al. The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model. Retina 1996;16:518-24.
21. Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol 1999;128:739-46.
22. Lewis H, Sakaguchi H. Pneumatic displacement of subretinal hemorrhage damages the retinal photoreceptors. Paper presented at: Naples, Florida, Macula Society Annual Meeting, 2003.
23. Haupert CL, McCuen BW II, Jaffe GJ, et al. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol 2001;131:208-15.
24. Olivier S, Chow DR, Packo KH, et al. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology 2004;111:1201-8.
25. Benner JD, Morse LS, Toth CA, et al. Evaluation of a commercial recombinant tissue-type plasminogen activator preparation in the subretinal space of the cat. Arch Ophthalmol 1991;109:1731-6.
26. Johnson MW, Olsen KR, Hernandez E, et al. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol 1990;108:259-63.
27. Irvine WD, Johnson MW, Hernandez E, et al. Retinal toxicity of human tissue recombinant tissue plasminogen activator in vitrectomized rabbit eyes. Arch Ophthalmol 1991;109:718-22.
28. Johnson MW, Olsen KR, Hernandez E. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Retina 1991;11:250-8.
29. Awh C. Pneumatic displacement of subretinal blood after vitrectomy and subretinal t-PA injection. Cancun, Mexico: paper presented at Vitreous Society Annual Meeting, 2001.